Moriyama N, Kurimoto S, Horie S, Nasu K, Tanaka T, Yano K, Hirano H, Tsujimoto G, Kawabe K
Department of Urology, Faculty of Medicine, University of Tokyo, Japan.
Histochem J. 1996 Apr;28(4):283-8. doi: 10.1007/BF02409016.
Adrenergic stimulation induces contraction of hypertrophied prostatic tissue via the alpha 1 adrenoceptor, and the results of pharmacological studies suggested the existence of adrenoceptor subtypes. Recently three subtypes (alpha 1a, alpha 1b, and alpha 1d) were cloned. Using probes for these subtypes, we demonstrated their expression in the tissues of ten cases of benign prostatic hypertrophy, using in situ hybridization. To determine the ratio between these subtypes, an RNase protection assay was also performed in three cases. Expression of the alpha 1a and alpha 1d adrenoceptors was diffuse in the smooth muscles of the interstitium, but was absent in glandular epithelial cells. On the contrary, the alpha 1b adrenoceptor was hardly detectable. The RNase protection assay confirmed the absence of the alpha 1b adrenoceptor, the ratio of alpha 1a and alpha 1d being 4:1. These results supported the idea that the differences in prostatic contractile response to several adrenergic drugs are based on the affinities of these drugs for the different subtypes.
肾上腺素能刺激通过α1肾上腺素受体诱导前列腺增生组织收缩,药理学研究结果提示存在肾上腺素受体亚型。最近克隆出了三种亚型(α1a、α1b和α1d)。我们使用针对这些亚型的探针,通过原位杂交技术在10例良性前列腺增生组织中证实了它们的表达。为了确定这些亚型之间的比例,还对3例组织进行了核糖核酸酶保护分析。α1a和α1d肾上腺素受体在间质平滑肌中呈弥漫性表达,但在腺上皮细胞中未表达。相反,α1b肾上腺素受体几乎检测不到。核糖核酸酶保护分析证实不存在α1b肾上腺素受体,α1a与α1d的比例为4:1。这些结果支持了以下观点,即前列腺对几种肾上腺素能药物的收缩反应差异是基于这些药物对不同亚型的亲和力。